AMICUS THERAPEUTICS, INC. — Director's Dealing 2017

Jan 17, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2017-01-13

Reporting Person: Do Hung (Chief Science Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-01-13	Common Stock	S	25000	$6.00	Disposed	559266	Direct

Footnotes

F1: The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2016.